CELG
Celgene Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.
Market Cap: 77 Billion
Primary Exchange: NASDAQ
Website: http://www.celgene.com
Shares Outstanding: 712 Million
Float: 711 Million
Dividend: (%)
Beta: 0.5791476794079837
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 723 trading days
From: 2017-10-04 To: 2019-11-19
Lowest Point:
Celgene's Long Journey Through Regulatory Filings For Ozanimod Might Finally Pay Off
via: SeekingAlpha at 2019-06-12 07:58:28:000
Celgene ( CELG ) is in good shape in terms of its multiple sclerosis ((MS)) drug ozanimod. That's because it announced that regulatory applications for the drug was accepted by both the FDA and EMA. This gives the company the potential to obtain approval for both territories. Getting thi… read more...
Celgene's Long Journey Through Regulatory Filings For Ozanimod Might Finally Pay Off
via: SeekingAlpha at 2019-06-12 07:58:28:000
Celgene ( CELG ) is in good shape in terms of its multiple sclerosis ((MS)) drug ozanimod. That's because it announced that regulatory applications for the drug was accepted by both the FDA and EMA. This gives the company the potential to obtain approval for both territories. Getting thi… read more...
How To Find Undervalued Stocks In The Healthcare Sector
via: SeekingAlpha at 2019-06-10 12:10:41:000
The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...
How To Find Undervalued Stocks In The Healthcare Sector
via: SeekingAlpha at 2019-06-10 12:10:41:000
The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2014-06-26 | 2014-02-12 | 2014-06-18 | 2014-06-25 00:00:00 -0400 | 0.5 | 2.0 | 1.0 |